---

---

therapeutics   tags : Presentation   

save search

---

NeuroSense Presents Positive Data Validating Phase 2b Topline Readout During Emerging Science Presentation at the American Academy of Neurology Annual Meeting
Published: 2024-04-18 (Crawled : 13:00) - neurosense.investorroom.com
NRSN | News | $1.51 -5.63% -5.96% 270K |

| -5.0% | O: -0.63% H: 1.89% C: -4.4%
neurology presentation readout positive topline meeting

---

Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
MNPR | News | $0.688 5.04% 4.8% 78K |

Health Technology

| 3.55% | O: 3.55% H: 0.0% C: 0.0%
nuclear presentation for meeting imaging molecular

---

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M |

Health Technology

| -5.02% | O: -3.94% H: 3.0% C: -0.57%
briumvi neurology presentation sclerosis for meeting therapeutics

---

Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
TRVI | $2.68 3.88% 3.73% 180K |

Health Technology

| -12.23% | O: 2.77% H: 1.59% C: -8.57%
conference presentation international therapeutics

---

Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
Published: 2024-04-07 (Crawled : 00:00) - globenewswire.com
BDTX A | $5.295 -7.11% -7.65% 1.9M |

Health Technology

| 8.03% | O: 5.22% H: 3.44% C: 2.1%
bdtx-1535 association presentation cancer research for meeting therapeutics

---

TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
TCRX 1 d | $6.9 2.22% 2.17% 250K |

Professional, Scientific, and T...

| -16.62% | O: -1.3% H: 0.0% C: -9.89%
conference presentation therapeutics

---

Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
CADL | $5.49 0.92% 0.91% 740K |

| Email alert Add to watchlist
can-3110 drug presentation update trial therapeutics glioblastoma

---

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-03-28 (Crawled : 20:00) - prnewswire.com
HRTX | $2.71 -2.17% -2.21% 1.8M |

Health Technology

| Email alert Add to watchlist
conference presentation therapeutics

---

Kazia announces presentation of new data at AACR Annual Meeting
Published: 2024-03-13 (Crawled : 13:30) - biospace.com/
KZIA | $0.3522 2.32% 2.27% 270K |

Health Technology

| 64.33% | O: -0.19% H: 11.33% C: 8.57%
presentation meeting

---

Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference
Published: 2024-03-13 (Crawled : 11:00) - globenewswire.com
UNCY | $1.09 -5.63% -5.96% 890K |

Professional, Scientific, and T...

| -23.78% | O: 1.75% H: 1.03% C: -4.47%
uni-494 conference presentation therapeutics

---

Late-Breaking Presentation at American Academy of Dermatology 2024 Annual Meeting Shows that JNJ-2113, the First and Only Investigational Targeted Oral Peptide, Maintained Skin Clearance in Moderate-To-Severe Plaque Psoriasis Through One Year
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
PTGX | $25.23 -1.33% -1.35% 390K |

Health Technology

| -16.82% | O: 0.0% H: 1.45% C: -0.66%
jnj-2113 first year presentation psoriasis one clearance meeting skin

---

Blacksmith Medicines Announces Upcoming Presentation at AACR Annual Meeting 2024
Published: 2024-03-06 (Crawled : 15:00) - prnewswire.com
CYT | $3.02 2.65% 1M |

Manufacturing

| -1.63% | O: 0.0% H: 0.65% C: -0.65%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| -3.45% | O: 0.86% H: 0.45% C: -0.58%
presentation meeting

---

ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-03-05 (Crawled : 23:00) - globenewswire.com
ADCT | $4.76 -4.03% 0.0% 280K |

Health Technology

| -1.24% | O: -0.21% H: 5.61% C: 3.95%
association presentation cancer research meeting therapeutics

---

Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024
Published: 2024-03-05 (Crawled : 22:00) - globenewswire.com
BDTX A | $5.295 -7.11% -7.65% 1.9M |

Health Technology

| 22.27% | O: 1.14% H: 1.8% C: -0.67%
presentation meeting therapeutics

---

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Published: 2024-03-01 (Crawled : 12:30) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M |

Health Technology

| -18.76% | O: 1.86% H: 4.79% C: 2.39%
briumvi presentation sclerosis treatment research therapeutics

---

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
Published: 2024-02-29 (Crawled : 14:00) - globenewswire.com
TENX | $3.67 2.23% 2.18% 21K |

Health Technology

| -11.11% | O: 1.69% H: 12.35% C: 9.03%
levosimendan presentation treatment therapeutics

---

Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting
Published: 2024-02-29 (Crawled : 13:00) - globenewswire.com
OCEA | $1.87 4.76% 4.55% 210K |

| 15.58% | O: 2.6% H: 36.71% C: 11.39%
first liver presentation global meeting therapeutics study

---

Invitation to the presentation of Calliditas´ Year-end report January - December 2023
Published: 2024-02-14 (Crawled : 07:00) - prnewswire.com
CALT | News | $18.3 -2.35% -2.4% 6.1K |

Health Technology

| -16.15% | O: -1.9% H: 1.88% C: 0.1%
report presentation

---

Celldex Announces Upcoming Presentation of Barzolvolimab Phase 2 Results in Chronic Spontaneous Urticaria at AAAAI 2024
Published: 2024-02-05 (Crawled : 13:00) - globenewswire.com
CLDX | $38.49 -2.88% -2.96% 580K |

Health Technology

| 9.55% | O: -1.1% H: 5.97% C: 5.43%
urticaria presentation results

---

Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
Published: 2024-01-30 (Crawled : 13:00) - globenewswire.com
PBLA | $1.15 -6.31% 360K |

Professional, Scientific, and T...

| -64.86% | O: 2.03% H: 0.66% C: -11.26%
sbp-101 association presentation cancer research

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---